Skip to main content

Articles

Page 43 of 65

  1. An in vitro model was developed to understand if celecoxib could synergize with Mitomycin C (MMC), commonly used for the prevention of non-muscle invasive bladder cancer recurrence, and eventually elucidate if th...

    Authors: Vincenzo Pagliarulo, Patrizia Ancona, Mauro Niso, Nicola Antonio Colabufo, Marialessandra Contino, Luigi Cormio, Amalia Azzariti and Arcangelo Pagliarulo
    Citation: Molecular Cancer 2013 12:47
  2. Although mammary cancer (MC) is the most common malignant neoplasia in women, the mortality for this cancer has decreased principally because of early detection and the use of neoadjuvant chemotherapy. Of seve...

    Authors: Yunuen Alfaro, Guadalupe Delgado, Alfonso Cárabez, Brenda Anguiano and Carmen Aceves
    Citation: Molecular Cancer 2013 12:45
  3. All-trans retinoic acid (ATRA) is currently being used in clinical trials for cancer treatment. The use of ATRA is limited because some cancers, such as lung cancer, show resistance to treatment. However, little ...

    Authors: Alejandro García-Regalado, Miguel Vargas, Alejandro García-Carrancá, Elena Aréchaga-Ocampo and Claudia Haydée González-De la Rosa
    Citation: Molecular Cancer 2013 12:44
  4. MicroRNAs(miRNA) are noncoding RNAs of about 19–23 nucleotides that are crucial for many biological processes. Members of the microRNA-148/152(miR-148/152) family, which include microRNA-148a(miR-148a), microR...

    Authors: Yue Chen, Yong-Xi Song and Zhen-Ning Wang
    Citation: Molecular Cancer 2013 12:43
  5. It has been shown in many solid tumors that the overexpression of the pro-survival Bcl-2 family members Bcl-2/Bcl-xL and Mcl-1 confers resistance to a variety of chemotherapeutic agents. We designed the BH3 α-...

    Authors: Xiaobo Cao, Jeremy L Yap, M Karen Newell-Rogers, Chander Peddaboina, Weihua Jiang, Harry T Papaconstantinou, Dan Jupitor, Arun Rai, Kwan-Young Jung, Richard P Tubin, Wenbo Yu, Kenno Vanommeslaeghe, Paul T Wilder, Alexander D MacKerell JR, Steven Fletcher and Roy W Smythe
    Citation: Molecular Cancer 2013 12:42
  6. Patients with familial adenomatous polyposis (FAP) are at increased risk for the development of colorectal cancer. Surgery and chemoprevention are the most effective means to prevent cancer development. Thymoq...

    Authors: Michaela Lang, Melanie Borgmann, Georg Oberhuber, Rayko Evstatiev, Kristine Jimenez, Kyle W Dammann, Manuela Jambrich, Vineeta Khare, Christoph Campregher, Robin Ristl and Christoph Gasche
    Citation: Molecular Cancer 2013 12:41
  7. Co-Activator Arginine Methyltransferase 1(CARM1) is an Estrogen Receptor (ER) cofactor that remodels chromatin for gene regulation via methylation of Histone3. We investigated CARM1 levels and localization acr...

    Authors: Melissa B Davis, Xinyu Liu, Shiyao Wang, Jaxk Reeves, Andrey Khramtsov, Dezheng Huo and Olufunmilayo I Olopade
    Citation: Molecular Cancer 2013 12:40
  8. Infection with high-risk human papillomavirus (HR-HPV) genotypes, mainly HPV16 and HPV18, is a major risk factor for cervical cancer and responsible for its progression. While the transforming role of the HPV ...

    Authors: Deborah French, Francesca Belleudi, Maria Vittoria Mauro, Francesca Mazzetta, Salvatore Raffa, Vincenza Fabiano, Antonio Frega and Maria Rosaria Torrisi
    Citation: Molecular Cancer 2013 12:38
  9. In a previous report, we described the in vitro and in vivo antiproliferative and proapoptotic activity of a hydroxylated biphenyl (D6), a structural analogue of curcumin, on malignant melanoma and neuroblastoma ...

    Authors: Carla Rozzo, Manuela Fanciulli, Cristina Fraumene, Antonio Corrias, Tiziana Cubeddu, Ilaria Sassu, Sara Cossu, Valentina Nieddu, Grazia Galleri, Emanuela Azara, Maria Antonietta Dettori, Davide Fabbri, Giuseppe Palmieri and Marina Pisano
    Citation: Molecular Cancer 2013 12:37
  10. The t(9;22)(q34;q11) generating the BCR/ABL1 fusion gene represents the cytogenetic hallmark of chronic myeloid leukemia (CML). About 5–10% of CML cases show variant translocations with the involvement of other c...

    Authors: Francesco Albano, Antonella Zagaria, Luisa Anelli, Nicoletta Coccaro, Luciana Impera, Crescenzio Francesco Minervini, Angela Minervini, Antonella Russo Rossi, Giuseppina Tota, Paola Casieri and Giorgina Specchia
    Citation: Molecular Cancer 2013 12:36
  11. The eukaryotic translation initiation factor 5A1 (eIF5A1) is a highly conserved protein involved in many cellular processes including cell division, translation, apoptosis, and inflammation. Induction of apopt...

    Authors: Catherine A. Taylor, Qifa Zheng, Zhongda Liu and John E. Thompson
    Citation: Molecular Cancer 2013 12:35
  12. Prior to the introduction of tamoxifen, high dose estradiol was used to treat breast cancer patients with similar efficacy as tamoxifen, albeit with some undesirable side effects. There is renewed interest to ...

    Authors: Bethany Perez White, Mary Ellen Molloy, Huiping Zhao, Yiyun Zhang and Debra A. Tonetti
    Citation: Molecular Cancer 2013 12:34

    The Retraction Note to this article has been published in Molecular Cancer 2017 16:121

  13. Surface-expressed Na+/K+-ATPase (NaK) has been suggested to function as a non-canonical cardiotonic steroid-binding receptor that activates multiple signaling cascades, especially in cancer cells. By contrast, th...

    Authors: Laetitia Moreno Y Banuls, Adriana Katz, Walter Miklos, Alessio Cimmino, Daniel M. Tal, Elena Ainbinder, Martin Zehl, Ernst Urban, Antonio Evidente, Brigitte Kopp, Walter Berger, Olivier Feron, Steven Karlish and Robert Kiss
    Citation: Molecular Cancer 2013 12:33
  14. Treatment of advanced stage ovarian cancer continues to be challenging due to acquired drug resistance and lack of early stage biomarkers. Genes identified to be aberrantly expressed at the 3q26.2 locus (i.e. ...

    Authors: Karthik M. Kodigepalli, Pavana Anur, Paul Spellman, Peter J. Sims and Meera Nanjundan
    Citation: Molecular Cancer 2013 12:32
  15. Expression of the constitutively activated mutant EGFR variant III (EGFRvIII), the most common mutation in glioblastoma multiforme (GBMs), has been clinically correlated with tumor proliferation, invasion, and...

    Authors: Yasufumi Katanasaka, Yasuo Kodera, Yuka Kitamura, Tatsuya Morimoto, Tomohide Tamura and Fumiaki Koizumi
    Citation: Molecular Cancer 2013 12:31
  16. Colorectal carcinoma (CRC) is one of the leading causes of cancer-related mortality worldwide. MicroRNAs (miRNAs, miRs) play important roles in carcinogenesis. MiR-32 has been shown to be upregulated in CRC. I...

    Authors: Weiyun Wu, Jingfang Yang, Xiao Feng, Hao Wang, Shicai Ye, Pengchun Yang, Wenkai Tan, Guoli Wei and Yu Zhou
    Citation: Molecular Cancer 2013 12:30
  17. Stalled replication forks at common fragile sites are a major cause of genomic instability. RecQ helicases, a highly conserved family of DNA-unwinding enzymes, are believed to ease ‘roadblocks’ that pose chall...

    Authors: Xing Lu, Swetha Parvathaneni, Toshifumi Hara, Ashish Lal and Sudha Sharma
    Citation: Molecular Cancer 2013 12:29
  18. CRIP1 (cysteine-rich intestinal protein 1) has been found in several tumor types, its prognostic impact and its role in cellular processes, particularly in breast cancer, are still unclear.

    Authors: Natalie Ludyga, Sonja Englert, Kerstin Pflieger, Sandra Rauser, Herbert Braselmann, Axel Walch, Gert Auer, Heinz Höfler and Michaela Aubele
    Citation: Molecular Cancer 2013 12:28
  19. The Vav family of Rho/Rac guanosine nucleotide exchange factors comprises three members in mammalian cells. Vav3 enhances androgen receptor (AR) activity during progression to androgen independence in prostate...

    Authors: Takeo Nomura, Mutsushi Yamasaki, Kenichi Hirai, Toru Inoue, Ryuta Sato, Keiko Matsuura, Masatsugu Moriyama, Fuminori Sato and Hiromitsu Mimata
    Citation: Molecular Cancer 2013 12:27
  20. The identification of potential tumor markers can improve therapeutic planning and patient management. The aim of this study was to highlight the significance of IL-6 in esophageal squamous cell carcinoma (SCC).

    Authors: Miao-Fen Chen, Ping-Tsung Chen, Ming Shian Lu, Paul Yang Lin, Wen-Cheng Chen and Kuan-Der Lee
    Citation: Molecular Cancer 2013 12:26
  21. The biomarker identification of human esophageal cancer is critical for its early diagnosis and therapeutic approaches that will significantly improve patient survival. Specially, those that involves in progre...

    Authors: Liang Wang, Jie Chen, Longqi Chen, Pengchi Deng, Qian bu, Pu Xiang, Manli Li, Wenjie Lu, Youzhi Xu, Hongjun Lin, Tianming Wu, Huijuan Wang, Jing Hu, Xiaoni Shao, Xiaobo Cen and Ying-Lan Zhao
    Citation: Molecular Cancer 2013 12:25
  22. Over 80% of women diagnosed with advanced-stage ovarian cancer die as a result of disease recurrence due to failure of chemotherapy treatment. In this study, using two distinct ovarian cancer cell lines (epith...

    Authors: Khalid Abubaker, Ardian Latifi, Rod Luwor, Simon Nazaretian, Hongjian Zhu, Michael A Quinn, Erik W Thompson, Jock K Findlay and Nuzhat Ahmed
    Citation: Molecular Cancer 2013 12:24
  23. Neuroblastoma is responsible for 15% of all childhood cancer deaths. Despite advances in treatment and disease management, the overall 5-year survival rates remain poor in high-risk disease (25-40%). MiR-497 w...

    Authors: Laura Creevey, Jacqueline Ryan, Harry Harvey, Isabella M Bray, Maria Meehan, Adnan R Khan and Raymond L Stallings
    Citation: Molecular Cancer 2013 12:23
  24. Anoikis resistance is one of the abilities acquired along tumor progression. This characteristic is associated with metastasis development, since tumorigenic cells must survive indepen...

    Authors: Mariana Toricelli, Fabiana HM Melo, Giovani B Peres, Débora CP Silva and Miriam G Jasiulionis
    Citation: Molecular Cancer 2013 12:1095
  25. Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) is a phosphatase having both protein and lipid phosphatase activities, and is known to antagonize the phosphoinositide 3-kinase/AKT (PI3K/AKT) s...

    Authors: Chunhua Yang, Shujing Li, Miao Wang, Alan K Chang, Ying Liu, Feng Zhao, Liyun Xiao, Lin Han, Dao Wang, Shen Li and Huijian Wu
    Citation: Molecular Cancer 2013 12:21
  26. Arsenic is a well-known human carcinogen, which potentially affects ~160 million people worldwide via exposure to unsafe levels in drinking water. Lungs are one of the main target organs for arsenic-related ca...

    Authors: Roland Hubaux, Daiana D Becker-Santos, Katey SS Enfield, David Rowbotham, Stephen Lam, Wan L Lam and Victor D Martinez
    Citation: Molecular Cancer 2013 12:20
  27. Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KI...

    Authors: Kerstin Maria Kampa-Schittenhelm, Michael Charles Heinrich, Figen Akmut, Hartmut Döhner, Konstanze Döhner and Marcus Matthias Schittenhelm
    Citation: Molecular Cancer 2013 12:19
  28. Metastasis in medulloblastoma (MB) is associated with poor survival. Recent genetic studies revealed MB to comprise distinct molecular subgroups, including the sonic hedgehog (SHH) subgroup that exhibits a rel...

    Authors: Liangping Yuan, Hongying Zhang, Jingbo Liu, Joshua B Rubin, Yoon-Jae Cho, Hui Kuo Shu, Matthew Schniederjan and Tobey J MacDonald
    Citation: Molecular Cancer 2013 12:18
  29. The studies reported herein were undertaken to determine if the angiostatic function of p53 could be exploited as an adjunct to VEGF-targeted therapy in the treatment of renal cell carcinoma (RCC).

    Authors: David J Panka, Qingjun Liu, Andrew K Geissler and James W Mier
    Citation: Molecular Cancer 2013 12:17

    The Retraction Note to this article has been published in Molecular Cancer 2021 20:89

  30. New therapies are urgently needed for patients with small cell lung cancer (SCLC). Chemotherapy and targeted therapies, including the Bcl-2 inhibitor ABT-737, may induce tumor cell autophagy. Autophagy can pro...

    Authors: Rebekah L Zinn, Eric E Gardner, Irina Dobromilskaya, Sara Murphy, Luigi Marchionni, Christine L Hann and Charles M Rudin
    Citation: Molecular Cancer 2013 12:16
  31. As 2013 commences I would like to take a moment to reflect and recognize the peer reviewers that made the previous year possible. Listed below are those people who reviewed for Molecular Cancer last year. All are...

    Authors: Alan Storey
    Citation: Molecular Cancer 2013 12:10
  32. Previously, using miRNA microarray, we have found that miR-29c is significantly downregulated in advanced gastric carcinoma. In the present study, we investigated whether miR-29c functions as a tumor-suppresso...

    Authors: Mitsuhiro Matsuo, Chisato Nakada, Yoshiyuki Tsukamoto, Tsuyoshi Noguchi, Tomohisa Uchida, Naoki Hijiya, Keiko Matsuura and Masatsugu Moriyama
    Citation: Molecular Cancer 2013 12:15
  33. Peripheral serotonin is involved in tumorigenesis and induces a pro-proliferative effect in hepatocellular carcinoma (HCC) cells; however, the intracellular mechanisms by which serotonin exerts a mitogenic eff...

    Authors: Chao Liang, Wei Chen, Xiao Zhi, Tao Ma, Xuefeng Xia, Hao Liu, Qi Zhang, Qida Hu, Yun Zhang, Xueli Bai and Tingbo Liang
    Citation: Molecular Cancer 2013 12:14
  34. Ultraconserved regions (UCR) are genomic segments of more than 200 base pairs that are evolutionarily conserved among mammalian species. They are thought to have functions as transcriptional enhancers and regu...

    Authors: Robert S Hudson, Ming Yi, Natalia Volfovsky, Robyn L Prueitt, Dominic Esposito, Stefano Volinia, Chang-Gong Liu, Aaron J Schetter, Katrien Van Roosbroeck, Robert M Stephens, George A Calin, Carlo M Croce and Stefan Ambs
    Citation: Molecular Cancer 2013 12:13
  35. Palytoxin (PTX), a marine toxin isolated from the Cnidaria (zooanthid) Palythoa caribaeorum is one of the most potent non-protein substances known. It is a very complex molecule that presents both lipophilic and ...

    Authors: Tibor Görögh, László Bèress, Elgar S Quabius, Petra Ambrosch and Markus Hoffmann
    Citation: Molecular Cancer 2013 12:12
  36. The continued discovery of therapeutic antibodies, which address unmet medical needs, requires the continued discovery of tractable antibody targets. Multiple protein-level target discovery approaches are avai...

    Authors: Steven Rust, Sandrine Guillard, Kris Sachsenmeier, Carl Hay, Max Davidson, Anders Karlsson, Roger Karlsson, Erin Brand, David Lowne, John Elvin, Matt Flynn, Gene Kurosawa, Robert Hollingsworth, Lutz Jermutus and Ralph Minter
    Citation: Molecular Cancer 2013 12:11
  37. Estrogen receptor-α (ERα)-negative breast cancer is clinically aggressive and normally does not respond to conventional estrogen target-directed therapies. The soybean isoflavone, genistein (GE), has been show...

    Authors: Yuanyuan Li, Syed M Meeran, Shweta N Patel, Huaping Chen, Tabitha M Hardy and Trygve O Tollefsbol
    Citation: Molecular Cancer 2013 12:9
  38. Vascular Endothelial Growth Factor (VEGF) is regulated by a number of different factors, but the mechanism(s) behind androgen-mediated regulation of VEGF in prostate cancer are poorly understood.

    Authors: Kurtis Eisermann, Carly J Broderick, Anton Bazarov, Mustafa M Moazam and Gail C Fraizer
    Citation: Molecular Cancer 2013 12:7
  39. NUP98 gene rearrangements have been reported in acute myeloid leukemia, giving rise to fusion proteins that seem to function as aberrant transcription factors, and are thought to be associated with poor prognosis...

    Authors: Susana Lisboa, Nuno Cerveira, Susana Bizarro, Cecília Correia, Joana Vieira, Lurdes Torres, José M Mariz and Manuel R Teixeira
    Citation: Molecular Cancer 2013 12:5
  40. During metaphase clathrin stabilises the mitotic spindle kinetochore(K)-fibres. Many anti-mitotic compounds target microtubule dynamics. Pitstop 2â„¢ is the first small molecule inhibitor of clathrin terminal do...

    Authors: Charlotte M Smith, Volker Haucke, Adam McCluskey, Phillip J Robinson and Megan Chircop
    Citation: Molecular Cancer 2013 12:4
  41. ADAMTS-1 (a disintegrin and metalloprotease with thrombospondin motifs) is a member of the ADAMTS family of metalloproteases. Here, we investigated mRNA and protein levels of ADAMTS-1 in normal and neoplastic ...

    Authors: Vanessa M Freitas, Jônatas Bussador do Amaral, Thaiomara A Silva, Emerson S Santos, Flávia R Mangone, João de Jesus Pinheiro, Ruy G Jaeger, Maria A Nagai and Gláucia Maria Machado-Santelli
    Citation: Molecular Cancer 2013 12:2
  42. Prevalence of colorectal cancer (CRC) in the British Bangladeshi population (BAN) is low compared to British Caucasians (CAU). Genetic background may influence mutations and disease features.

    Authors: Neel Sengupta, Christopher Yau, Anuratha Sakthianandeswaren, Dmitri Mouradov, Peter Gibbs, Nirosha Suraweera, Jean-Baptiste Cazier, Guadalupe Polanco-Echeverry, Anil Ghosh, Mohamed Thaha, Shafi Ahmed, Roger Feakins, David Propper, Sina Dorudi, Oliver Sieber, Andrew Silver…
    Citation: Molecular Cancer 2013 12:1
  43. The epidermal growth factor receptor (EGFR) is an established target for anti-cancer treatment in different tumour types. Two different strategies have been explored to inhibit this pivotal molecule in epithel...

    Authors: Andrea Cavazzoni, Roberta R Alfieri, Daniele Cretella, Francesca Saccani, Luca Ampollini, Maricla Galetti, Federico Quaini, Gallia Graiani, Denise Madeddu, Paola Mozzoni, Elena Galvani, Silvia La Monica, Mara Bonelli, Claudia Fumarola, Antonio Mutti, Paolo Carbognani…
    Citation: Molecular Cancer 2012 11:91
  44. The CCAAT/enhancer binding proteins (C/EBPs) play important roles in carcinogenesis of many tumors including the lung. Since multiple C/EBPs are expressed in lung, the combinatorial expression of these C/EBPs ...

    Authors: Shioko Kimura, Jorge Paiz, Mitsuhiro Yoneda, Taketomo Kido, Charles Vinson and Jerrold M Ward
    Citation: Molecular Cancer 2012 11:90
  45. Transgenes introduced into cancer cell lines serve as powerful tools for identification of genes involved in cancer. However, the random nature of genomic integration site of a transgene highly influences the ...

    Authors: Iacovos P Michael, Claudio Monetti, Anthony C Chiu, Puzheng Zhang, Takeshi Baba, Koichiro Nishino, Siamak Agha-Mohammadi, Knut Woltjen, Hoon-Ki Sung and Andras Nagy
    Citation: Molecular Cancer 2012 11:89
  46. Pancreatic cancer is characterized by constitutive activation of mitogen-activated protein kinase (MAPK). Activation of MAPK is associated with the upregulation of genes implicated in the proliferation and sur...

    Authors: Toru Furukawa, Etsuko Tanji, Yuko Kuboki, Takashi Hatori, Masakazu Yamamoto, Kyoko Shimizu, Noriyuki Shibata and Keiko Shiratori
    Citation: Molecular Cancer 2012 11:88
  47. IL-1β is a pleiotropic pro-inflammatory cytokine and its up-regulation is closely associated with various cancers including gastrointestinal tumors. However, it remains unclear how IL-1β may contribute to the ...

    Authors: Yijing Li, Lei Wang, Loretta Pappan, Amy Galliher-Beckley and Jishu Shi
    Citation: Molecular Cancer 2012 11:87

Annual Journal Metrics

  • 2022 Citation Impact
    37.3 - 2-year Impact Factor
    33.1 - 5-year Impact Factor
    5.740 - SNIP (Source Normalized Impact per Paper)
    8.703 - SJR (SCImago Journal Rank)

    2023 Speed
    5 days submission to first editorial decision for all manuscripts (Median)
    91 days submission to accept (Median)

    2023 Usage 
    3,569,666 downloads
    2,070 Altmetric mentions